Thymic carcinoma diagnostic study of choice

Revision as of 04:49, 10 February 2019 by Shyam Patel (talk | contribs) (Created page with "__NOTOC__ {{Thymic carcinoma}} {{CMG}} {{shyam}}; {{AE}}{{PSD}} ==Overview== The staging of thymic carcinoma is based on the Masoka and GETT staging system.<ref name="pmid804...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Thymic Carcinoma Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thymic carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Thymic carcinoma diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Thymic carcinoma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thymic carcinoma diagnostic study of choice

CDC on Thymic carcinoma diagnostic study of choice

Thymic carcinoma diagnostic study of choice in the news

Blogs on Thymic carcinoma diagnostic study of choice

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Thymic carcinoma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [3]

Overview

The staging of thymic carcinoma is based on the Masoka and GETT staging system.[1]

Diagnostic study of choice

The diagnostic study of choice for thymic carcinoma is tissue biopsy.[2]

References

  1. Masaoka A, Yamakawa Y, Niwa H, Fukai I, Saito Y, Tokudome S; et al. (1994). "Thymectomy and malignancy". Eur J Cardiothorac Surg. 8 (5): 251–3. PMID 8043287.
  2. Akiyama T, Miyamoto Y, Nomoto D, Kiyozumi Y, Eto K, Hiyoshi Y; et al. (2019). "Laparoscopic dissection for pelvic lymph node recurrence of thymic carcinoma: A case report". Asian J Endosc Surg. doi:10.1111/ases.12688. PMID 30714349.